Pharmaceuticals
CEO of Salonpas maker seeks to take the 450 billion yen drug firm private
The Japanese government has been promoting cheaper generic medicines and pushing drugmakers to cut prices as its population ages
Pfizer forecasts 2026 profit below expectations on lower Covid product sales
Pfizer has rolled out a sweeping cost reduction programme in response to the drop in Covid-19 sales
Novartis strikes deal with UK biotech for up to US$1.7 billion
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences
Malaysia’s retail pharmacy boom draws billion-ringgit bets as IPO pipeline builds
The catalyst – news that BIG Caring Group is weighing a blockbuster listing in Bursa Malaysia next year
Chemistry AI startup ChemLex raises US$45 million, sets up global HQ in Singapore
The funds will be used to hire more hardware and software engineers as well as chemists in the city-state
US, UK announce deal on pharmaceutical tariffs, drug pricing
[WASHINGTON] The Trump administration has reached an agreement with the UK to allow tariff-free imports of pharmaceutical products in exchange for a significant reduction in rebates drugmakers pay to ...
What China will dominate next
The country’s high-speed innovation holds lessons for the world
Singapore’s October factory output records highest jump in 15 years, up 29.1% on pharma surge
This surprised private-sector economists who had expected a 6.7% growth
Pharmaceutical chain Big Caring weighs Malaysia IPO next year at up to RM20 billion valuation: sources
It could raise as much as RM6 billion, making it one of Malaysia’s biggest listings in years
J&J to buy Halda Therapeutics in US$3.05 billion cash deal
[NEW YORK] Johnson & Johnson has agreed to buy the cancer treatment biotech Halda Therapeutics for US$3.05 billion cash, part of a strategy to cope with eroding sales for its major psoriasis drug.
